Toward Harmonized Relapse & Severity Adjudication is a 1-hour enduring CME activity within the NMOSD Grand Rounds educational series. This session focuses on improving clinician understanding of relapse recognition and severity classification in neuromyelitis optica spectrum disorder (NMOSD). The activity reviews the clinical spectrum and frequency of NMOSD relapses and examines standardized criteria used to diagnose relapse events and categorize severity. Faculty discuss anatomic localization, targeted neurologic deficits, and structured assessment approaches used in both clinical and research settings. The session also introduces web-based adjudication frameworks designed to support accurate relapse identification and severity classification. Through evidence-based discussion and practical examples, this activity is designed to improve clinician competence in applying consistent, structured approaches to relapse adjudication in NMOSD.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- 50 Division Street
Pricing
CME included with membership
| Free CME Activity | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- Clinical Informatics
- Dermatology
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Medical Leadership & Administration
- Medical Oncology
- Neonatal-Perinatal Medicine
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Pediatric Neurology
- Sleep Medicine
- Surgical Oncology
- Urological Oncology
- Vascular Neurology
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedMay 30, 2025
-
Last day to claim creditDec 1, 2026 7 weeks left
-
PeerVoice, Siyemi Europe Limited PeerVoice – Recognising Progression Beyond Relapse: Clinical Challenges and Emerging Approaches in Progressive MS
-
PVI, PeerView Institute for Medical Education Quiet Progression, Loud Impact: Expert Insights on the Role of BTK Inhibitors Beyond Relapse in MS
-
American Institute of Ultrasound in Medicine Grading Sonographic Severity of Adenomyosis
